<http://webisa.webdatacommons.org/249164261>	<http://www.w3.org/ns/prov#value>	"Compared to the conventional way of guiding radiation to tumors with radiolabeled antibody, pretargeted radioimmunotherapy offers an attractive potential alternative because the delivery of therapeutic isotope is rapid and is separated from the long antibody delivery process, thereby reducing the harmful effects of radiation to the body, especially the bone marrow, says Rafke Schoffelen, MD, sci" .
<http://webisa.webdatacommons.org/prov/494949476>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/249164261> .
<http://webisa.webdatacommons.org/249164261>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<eurekalert.org> .
<http://webisa.webdatacommons.org/249164261>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .